세계의 흡입 캡슐 시장 - 기회 분석 및 산업 예측(2023-2032년)

The global inhalation capsule market is anticipated to reach $1,464.9 million by 2032, growing from $822.4 million in 2022 at a CAGR of 6.4 % from 2023 to 2032.

Inhalation capsules' capacity to deliver medications directly to the lungs allows for quick and concentrated treatment of respiratory illnesses. This customized administration strategy minimizes systemic side effects while boosting therapeutic efficacy. Typically, capsules are designed to be used with specialized inhalation devices such as dry powder inhalers (DPIs) or metered-dose inhalers (MDIs). As the pharmaceutical industry continues to look for new and more effective ways to provide medication, inhalation capsules are emerging as a viable option.

One of the key reasons projected to drive the market growth is the exceptional efficacy of medicine delivery achieved by inhalation. The respiratory system offers a direct and efficient route to the circulation, allowing medication activity to begin immediately. This is particularly crucial for treating diseases characterized by severe aggravations, as quick relief is required. The lungs provide a huge surface area for drug absorption, and the thin alveolar membranes allow therapeutic chemicals to reach the bloodstream rapidly. As a result, inhalation capsules give a more rapid and direct pharmacological response than traditional oral delivery, allowing patients to experience quicker relief and better overall outcomes. The rapid onset of action increases the efficacy of inhalation capsules.

Stringent regulatory framework that oversees pharmaceutical products, particularly inhalation capsules is one of the major factors anticipated to hamper the market revenue growth. Regulatory authorities use strict criteria and processes to ensure that pharmaceuticals are safe, effective, and of high quality. Manufacturers need to stick to Good Manufacturing Practices (GMP), which requires maintaining complete control over every stage of the production process. Compliance with these regulations necessitates substantial investment in technology, equipment, and personnel training, which adds to the overall complexity of the production process. The intricate design and content of inhalation capsules contribute to their complexity. These capsules usually include specialized materials, such as polymers, that must meet stringent stability, compatibility, and biocompatibility criteria.

Inhalation capsules provide pharmaceutical firms a unique chance to reformulate current medications or introduce novel chemicals that can be successfully given via the respiratory route. Inhalation capsule has the potential to revitalize drug development pipelines by providing benefits such as a faster start of action, less systemic adverse effects, and better patient compliance. The pharmaceutical sector may capitalize on these prospects by investing in R&D to produce inhalable formulations for a variety of therapeutic areas, including respiratory disorders, systemic ailments, and even vaccinations. All these factors are anticipated to create several growth opportunities in the inhalation capsules market during the forecast period.

The key players profiled in this report include Capsugel, Qualicaps, ACG Worldwide, Cipla, Novartis, AstraZeneca plc, Chiesi Farmaceutici S.p.A., Elpen S.A., Vectura Group Plc, and Boehringer Ingelheim GmbH. The market players are continuously striving to achieve a dominant position in this competitive market using strategies such as diversification of product portfolios & mergers and acquisitions.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the inhalation capsules market analysis from 2022 to 2032 to identify the prevailing inhalation capsules market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the inhalation capsules market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global inhalation capsules market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Manufacturing Capacity
• Product Life Cycles
• Go To Market Strategy
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• Market share analysis of players at global/region/country level
• SWOT Analysis

Key Market Segments

By Type

• Gelatin Capsules
• Hypromellose Capsules

By Application

• Asthma Treatment
• COPD Management
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Iltay
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Capsugel
• Qualicaps
• ACG Worldwide
• Cipla
• Novartis
• AstraZeneca Plc
• CHIESI Farmaceutici S.p.A.
• Elpen S.A.
• Vectura Group plc.
• Boehringer Ingelheim GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
• 3.4. Market dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities
• 3.5. Average Selling Price
• 3.6. Market Share Analysis
• 3.7. Brand Share Analysis
• 3.8. Trade Data Analysis
• 3.9. Product Consumption
• 3.10. Value Chain Analysis
• 3.11. Key Regulation Analysis
• 3.12. Patent Landscape
• 3.13. Regulatory Guidelines
• 3.14. Reimbursement Scenario

CHAPTER 4: INHALATION CAPSULES MARKET, BY TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Gelatin Capsules
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Hypromellose Capsules
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: INHALATION CAPSULES MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Asthma Treatment
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. COPD Management
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Others
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country

CHAPTER 6: INHALATION CAPSULES MARKET, BY REGION

• 6.1. Overview
  • 6.1.1. Market size and forecast By Region
• 6.2. North America
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by Type
  • 6.2.3. Market size and forecast, by Application
  • 6.2.4. Market size and forecast, by country
    • 6.2.4.1. U.S.
    • 6.2.4.1.1. Market size and forecast, by Type
    • 6.2.4.1.2. Market size and forecast, by Application
    • 6.2.4.2. Canada
    • 6.2.4.2.1. Market size and forecast, by Type
    • 6.2.4.2.2. Market size and forecast, by Application
    • 6.2.4.3. Mexico
    • 6.2.4.3.1. Market size and forecast, by Type
    • 6.2.4.3.2. Market size and forecast, by Application
• 6.3. Europe
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by Type
  • 6.3.3. Market size and forecast, by Application
  • 6.3.4. Market size and forecast, by country
    • 6.3.4.1. Germany
    • 6.3.4.1.1. Market size and forecast, by Type
    • 6.3.4.1.2. Market size and forecast, by Application
    • 6.3.4.2. UK
    • 6.3.4.2.1. Market size and forecast, by Type
    • 6.3.4.2.2. Market size and forecast, by Application
    • 6.3.4.3. France
    • 6.3.4.3.1. Market size and forecast, by Type
    • 6.3.4.3.2. Market size and forecast, by Application
    • 6.3.4.4. Spain
    • 6.3.4.4.1. Market size and forecast, by Type
    • 6.3.4.4.2. Market size and forecast, by Application
    • 6.3.4.5. Iltay
    • 6.3.4.5.1. Market size and forecast, by Type
    • 6.3.4.5.2. Market size and forecast, by Application
    • 6.3.4.6. Rest of Europe
    • 6.3.4.6.1. Market size and forecast, by Type
    • 6.3.4.6.2. Market size and forecast, by Application
• 6.4. Asia-Pacific
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by Type
  • 6.4.3. Market size and forecast, by Application
  • 6.4.4. Market size and forecast, by country
    • 6.4.4.1. China
    • 6.4.4.1.1. Market size and forecast, by Type
    • 6.4.4.1.2. Market size and forecast, by Application
    • 6.4.4.2. Japan
    • 6.4.4.2.1. Market size and forecast, by Type
    • 6.4.4.2.2. Market size and forecast, by Application
    • 6.4.4.3. India
    • 6.4.4.3.1. Market size and forecast, by Type
    • 6.4.4.3.2. Market size and forecast, by Application
    • 6.4.4.4. South Korea
    • 6.4.4.4.1. Market size and forecast, by Type
    • 6.4.4.4.2. Market size and forecast, by Application
    • 6.4.4.5. Australia
    • 6.4.4.5.1. Market size and forecast, by Type
    • 6.4.4.5.2. Market size and forecast, by Application
    • 6.4.4.6. Rest of Asia-Pacific
    • 6.4.4.6.1. Market size and forecast, by Type
    • 6.4.4.6.2. Market size and forecast, by Application
• 6.5. LAMEA
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by Type
  • 6.5.3. Market size and forecast, by Application
  • 6.5.4. Market size and forecast, by country
    • 6.5.4.1. Brazil
    • 6.5.4.1.1. Market size and forecast, by Type
    • 6.5.4.1.2. Market size and forecast, by Application
    • 6.5.4.2. Saudi Arabia
    • 6.5.4.2.1. Market size and forecast, by Type
    • 6.5.4.2.2. Market size and forecast, by Application
    • 6.5.4.3. United Arab Emirates
    • 6.5.4.3.1. Market size and forecast, by Type
    • 6.5.4.3.2. Market size and forecast, by Application
    • 6.5.4.4. South Africa
    • 6.5.4.4.1. Market size and forecast, by Type
    • 6.5.4.4.2. Market size and forecast, by Application
    • 6.5.4.5. Rest of LAMEA
    • 6.5.4.5.1. Market size and forecast, by Type
    • 6.5.4.5.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top winning strategies
• 7.3. Product mapping of top 10 player
• 7.4. Competitive dashboard
• 7.5. Competitive heatmap
• 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

• 8.1. Capsugel
  • 8.1.1. Company overview
  • 8.1.2. Key executives
  • 8.1.3. Company snapshot
• 8.2. Qualicaps
  • 8.2.1. Company overview
  • 8.2.2. Key executives
  • 8.2.3. Company snapshot
• 8.3. ACG Worldwide
  • 8.3.1. Company overview
  • 8.3.2. Key executives
  • 8.3.3. Company snapshot
• 8.4. Cipla
  • 8.4.1. Company overview
  • 8.4.2. Key executives
  • 8.4.3. Company snapshot
• 8.5. Novartis
  • 8.5.1. Company overview
  • 8.5.2. Key executives
  • 8.5.3. Company snapshot
• 8.6. AstraZeneca Plc
  • 8.6.1. Company overview
  • 8.6.2. Key executives
  • 8.6.3. Company snapshot
• 8.7. CHIESI Farmaceutici S.p.A.
  • 8.7.1. Company overview
  • 8.7.2. Key executives
  • 8.7.3. Company snapshot
• 8.8. Elpen S.A.
  • 8.8.1. Company overview
  • 8.8.2. Key executives
  • 8.8.3. Company snapshot
• 8.9. Vectura Group plc.
  • 8.9.1. Company overview
  • 8.9.2. Key executives
  • 8.9.3. Company snapshot
• 8.10. Boehringer Ingelheim GmbH
  • 8.10.1. Company overview
  • 8.10.2. Key executives
  • 8.10.3. Company snapshot